Vaccines
5 February 2021
First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research5 February 2021
Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization3 February 2021
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate3 February 2021
COVAXX Announces Initiation of Phase 2 Clinical Trials in Taiwan of UB-612 Vaccine Candidate against COVID-1929 January 2021
COVID-19 Vaccine AstraZeneca recommended for use in the EU26 January 2021
Providence Therapeutics announces first subject has been dosed in COVID-19 vaccine trial25 January 2021
BioVaxys Announces Initiation of Cancer Vaccine EU Clinical Program, Completion of BVX-0320 Preclinical Program24 January 2021
Vaxess Technologies Awarded NSF and DARPA Funding for Development of mRNA-Based Single-Dose, Refrigeration-Free Vaccine Patch21 January 2021
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of ‘EuCorVac-19’ in Korea21 January 2021
Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by TakedaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports